Research Overview
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Research-grade compounds of this class are studied in laboratory settings to understand their interactions with dual incretin receptor pathways and downstream metabolic effects.
Research Focus
Dual incretin receptor pathways
Related Compounds
Popular
Metabolic
Semaglutide
GLP-1 receptor agonist analog under investigation for metabolic pathway research.
COA Verified≥98% by HPLC
$89.99/ 2mg
For Laboratory Research Use Only